Corporate borrowing surged to a record in 2024, up over a third from a year earlier as companies like AbbVie and Cisco looked to fund acquisitions.

Abbvie Inc., Novartis, AstraZeneca and the Pharmaceutical Research and Manufacturers of America filed a legal challenge last ...

Shares of AbbVie Inc. ABBV inched 0.99% higher to $181.22 Friday, on what proved to be an all-around favorable trading ...

Researchers design a new way to more reliably evaluate AI models' ability to make clinical decisions in realistic scenarios that closely mimic real-life interactions. The analysis finds that ...

Halozyme provides subcutaneous drug delivery solutions, with several major new products recently approved. Click here to find ...

The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine ...

AbbVie Inc (ABBV) stock saw a modest uptick, ending the day at $179.44 which represents a slight increase of $1.74 or 0.98% from the prior close of $177.7. The stock opened at $178.66 and touched a ...

Companies like Pfizer, Amgen, AbbVie, Novartis, and others are advancing Opioid Use Disorder treatments, focusing on improving symptoms and patient ...

Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and ...

AbbVie will announce its full-year and fourth-quarter 2024 financial results on Friday, January 31, 2025, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV – Research Report), Palvella ...

GAMMA Investing LLC grew its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 9.5% during the fourth quarter, ...